Pelareorep FDA Fast Track designation opens a registrational path for a viral immunotherapy targeting advanced anal cancer ...
Dyne Therapeutics wins FDA Priority Review for DMD drug z-rostudirsen, with key catalysts and pipeline upside. Click for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results